Global and China Intracranial Atherosclerotic Disease Treatment Market Insights, Forecast to 2027

Report ID: 1015022 | Published Date: Jan 2025 | No. of Page: 137 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Intracranial Atherosclerotic Disease Treatment Product Introduction
    1.2 Market by Type
        1.2.1 Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Type
        1.2.2 Stent
        1.2.3 PTA Balloon
    1.3 Market by Application
        1.3.1 Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Application
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Intracranial Atherosclerotic Disease Treatment Market Size, Estimates and Forecasts
        2.1.1 Global Intracranial Atherosclerotic Disease Treatment Revenue 2016-2027
        2.1.2 Global Intracranial Atherosclerotic Disease Treatment Sales 2016-2027
    2.2 Global Intracranial Atherosclerotic Disease Treatment, Market Size by Region: 2016 VS 2021 VS 2027
    2.3 Intracranial Atherosclerotic Disease Treatment Historical Market Size by Region (2016-2021)
        2.3.1 Global Intracranial Atherosclerotic Disease Treatment Retrospective Market Scenario in Sales by Region: 2016-2021
        2.3.2 Global Intracranial Atherosclerotic Disease Treatment Retrospective Market Scenario in Revenue by Region: 2016-2021
    2.4 Intracranial Atherosclerotic Disease Treatment Market Estimates and Projections by Region (2022-2027)
        2.4.1 Global Intracranial Atherosclerotic Disease Treatment Sales Forecast by Region (2022-2027)
        2.4.2 Global Intracranial Atherosclerotic Disease Treatment Revenue Forecast by Region (2022-2027)

3 Global Intracranial Atherosclerotic Disease Treatment Competitor Landscape by Players
    3.1 Global Top Intracranial Atherosclerotic Disease Treatment Manufacturers by Sales
        3.1.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Manufacturer (2016-2021)
        3.1.2 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Manufacturer (2016-2021)
    3.2 Global Top Intracranial Atherosclerotic Disease Treatment Manufacturers by Revenue
        3.2.1 Key Intracranial Atherosclerotic Disease Treatment Manufacturers Covered: Ranking by Revenue
        3.2.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Manufacturers (2016-2021)
        3.2.3 Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Manufacturers (2016-2021)
        3.2.4 Global Intracranial Atherosclerotic Disease Treatment Market Concentration Ratio (CR5 and HHI) (2016-2021)
        3.2.5 Global Top 10 and Top 5 Companies by Intracranial Atherosclerotic Disease Treatment Revenue in 2020
        3.2.6 Global Intracranial Atherosclerotic Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Intracranial Atherosclerotic Disease Treatment Price by Manufacturers
    3.4 Global Intracranial Atherosclerotic Disease Treatment Manufacturing Base Distribution, Product Types
        3.4.1 Intracranial Atherosclerotic Disease Treatment Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Intracranial Atherosclerotic Disease Treatment Product Type
        3.4.3 Date of International Manufacturers Enter into Intracranial Atherosclerotic Disease Treatment Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
    4.1 Global Intracranial Atherosclerotic Disease Treatment Market Size by Type (2016-2021)
        4.1.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Type (2016-2021)
        4.1.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Type (2016-2021)
        4.1.3 Intracranial Atherosclerotic Disease Treatment Average Selling Price (ASP) by Type (2016-2021)
    4.2 Global Intracranial Atherosclerotic Disease Treatment Market Size Forecast by Type (2022-2027)
        4.2.1 Global Intracranial Atherosclerotic Disease Treatment Sales Forecast by Type (2022-2027)
        4.2.2 Global Intracranial Atherosclerotic Disease Treatment Revenue Forecast by Type (2022-2027)
        4.2.3 Intracranial Atherosclerotic Disease Treatment Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
    5.1 Global Intracranial Atherosclerotic Disease Treatment Market Size by Application (2016-2021)
        5.1.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Application (2016-2021)
        5.1.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Application (2016-2021)
        5.1.3 Intracranial Atherosclerotic Disease Treatment Price by Application (2016-2021)
    5.2 Intracranial Atherosclerotic Disease Treatment Market Size Forecast by Application (2022-2027)
        5.2.1 Global Intracranial Atherosclerotic Disease Treatment Sales Forecast by Application (2022-2027)
        5.2.2 Global Intracranial Atherosclerotic Disease Treatment Revenue Forecast by Application (2022-2027)
        5.2.3 Global Intracranial Atherosclerotic Disease Treatment Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
    6.1 China Intracranial Atherosclerotic Disease Treatment Market Size YoY Growth 2016-2027
        6.1.1 China Intracranial Atherosclerotic Disease Treatment Sales YoY Growth 2016-2027
        6.1.2 China Intracranial Atherosclerotic Disease Treatment Revenue YoY Growth 2016-2027
        6.1.3 China Intracranial Atherosclerotic Disease Treatment Market Share in Global Market 2016-2027
    6.2 China Intracranial Atherosclerotic Disease Treatment Market Size by Players (International and Local Players)
        6.2.1 China Top Intracranial Atherosclerotic Disease Treatment Players by Sales (2016-2021)
        6.2.2 China Top Intracranial Atherosclerotic Disease Treatment Players by Revenue (2016-2021)
    6.3 China Intracranial Atherosclerotic Disease Treatment Historic Market Review by Type (2016-2021)
        6.3.1 China Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2016-2021)
        6.3.2 China Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2016-2021)
        6.3.3 China Intracranial Atherosclerotic Disease Treatment Price by Type (2016-2021)
    6.4 China Intracranial Atherosclerotic Disease Treatment Market Estimates and Forecasts by Type (2022-2027)
        6.4.1 China Intracranial Atherosclerotic Disease Treatment Sales Forecast by Type (2022-2027)
        6.4.2 China Intracranial Atherosclerotic Disease Treatment Revenue Forecast by Type (2022-2027)
        6.4.3 China Intracranial Atherosclerotic Disease Treatment Price Forecast by Type (2022-2027)
    6.5 China Intracranial Atherosclerotic Disease Treatment Historic Market Review by Application (2016-2021)
        6.5.1 China Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2016-2021)
        6.5.2 China Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2016-2021)
        6.5.3 China Intracranial Atherosclerotic Disease Treatment Price by Application (2016-2021)
    6.6 China Intracranial Atherosclerotic Disease Treatment Market Estimates and Forecasts by Application (2022-2027)
        6.6.1 China Intracranial Atherosclerotic Disease Treatment Sales Forecast by Application (2022-2027)
        6.6.2 China Intracranial Atherosclerotic Disease Treatment Revenue Forecast by Application (2022-2027)
        6.6.3 China Intracranial Atherosclerotic Disease Treatment Price Forecast by Application (2022-2027)

7 North America
    7.1 North America Intracranial Atherosclerotic Disease Treatment Market Size YoY Growth 2016-2027
    7.2 North America Intracranial Atherosclerotic Disease Treatment Market Facts & Figures by Country
        7.2.1 North America Intracranial Atherosclerotic Disease Treatment Sales by Country (2016-2021)
        7.2.2 North America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2016-2021)
        7.2.3 United States
        7.2.4 Canada

8 Asia Pacific
    8.1 Asia Pacific Intracranial Atherosclerotic Disease Treatment Market Size YoY Growth 2016-2027
    8.2 Asia Pacific Intracranial Atherosclerotic Disease Treatment Market Facts & Figures by Region
        8.2.1 Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales by Region (2016-2021)
        8.2.2 Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue by Region (2016-2021)
        8.2.3 China
        8.2.4 Japan
        8.2.5 South Korea
        8.2.6 India
        8.2.7 Australia
        8.2.8 Australia
        8.2.9 Indonesia
        8.2.10 Thailand
        8.2.11 Malaysia

9 Europe
    9.1 Europe Intracranial Atherosclerotic Disease Treatment Market Size YoY Growth 2016-2027
    9.2 Europe Intracranial Atherosclerotic Disease Treatment Market Facts & Figures by Country
        9.2.1 Europe Intracranial Atherosclerotic Disease Treatment Sales by Country (2016-2021)
        9.2.2 Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country (2016-2021)
        9.2.3 Germany
        9.2.4 France
        9.2.5 U.K.
        9.2.6 Italy

10 Latin America
    10.1 Latin America Intracranial Atherosclerotic Disease Treatment Market Size YoY Growth 2016-2027
    10.2 Latin America Intracranial Atherosclerotic Disease Treatment Market Facts & Figures by Country
        10.2.1 Latin America Intracranial Atherosclerotic Disease Treatment Sales by Country (2016-2021)
        10.2.2 Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2016-2021)
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Market Size YoY Growth 2016-2027
    11.2 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Market Facts & Figures by Country
        11.2.1 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales by Country (2016-2021)
        11.2.2 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue by Country (2016-2021)
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 UAE

12 Company Profiles
    12.1 Stryker
        12.1.1 Stryker Corporation Information
        12.1.2 Stryker Description and Business Overview
        12.1.3 Stryker Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Stryker Intracranial Atherosclerotic Disease Treatment Products Offered
        12.1.5 Stryker Recent Development
    12.2 Balt
        12.2.1 Balt Corporation Information
        12.2.2 Balt Description and Business Overview
        12.2.3 Balt Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Balt Intracranial Atherosclerotic Disease Treatment Products Offered
        12.2.5 Balt Recent Development
    12.3 TERUMO
        12.3.1 TERUMO Corporation Information
        12.3.2 TERUMO Description and Business Overview
        12.3.3 TERUMO Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 TERUMO Intracranial Atherosclerotic Disease Treatment Products Offered
        12.3.5 TERUMO Recent Development
    12.4 MicroPort
        12.4.1 MicroPort Corporation Information
        12.4.2 MicroPort Description and Business Overview
        12.4.3 MicroPort Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 MicroPort Intracranial Atherosclerotic Disease Treatment Products Offered
        12.4.5 MicroPort Recent Development
    12.5 Acandis
        12.5.1 Acandis Corporation Information
        12.5.2 Acandis Description and Business Overview
        12.5.3 Acandis Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Acandis Intracranial Atherosclerotic Disease Treatment Products Offered
        12.5.5 Acandis Recent Development
    12.11 Stryker
        12.11.1 Stryker Corporation Information
        12.11.2 Stryker Description and Business Overview
        12.11.3 Stryker Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Stryker Intracranial Atherosclerotic Disease Treatment Products Offered
        12.11.5 Stryker Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Intracranial Atherosclerotic Disease Treatment Industry Trends
    13.2 Intracranial Atherosclerotic Disease Treatment Market Drivers
    13.3 Intracranial Atherosclerotic Disease Treatment Market Challenges
    13.4 Intracranial Atherosclerotic Disease Treatment Market Restraints

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Intracranial Atherosclerotic Disease Treatment Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables
    Table 1. Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Stent
    Table 3. Major Manufacturers of PTA Balloon
    Table 4. Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Application (2021-2027) & (K Units)
    Table 5. Global Intracranial Atherosclerotic Disease Treatment Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
    Table 6. Global Intracranial Atherosclerotic Disease Treatment Sales by Regions (2016-2021) & (K Units)
    Table 7. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Regions (2016-2021)
    Table 8. Global Intracranial Atherosclerotic Disease Treatment Revenue by Regions (2016-2021) & (US$ Million)
    Table 9. Global Intracranial Atherosclerotic Disease Treatment Sales Forecast by Region (2022-2027) & (K Units)
    Table 10. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share Forecast by Region (2022-2027)
    Table 11. Global Intracranial Atherosclerotic Disease Treatment Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 12. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share Forecast by Region (2022-2027)
    Table 13. Global Intracranial Atherosclerotic Disease Treatment Sales by Manufacturers (2016-2021) (K Units)
    Table 14. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Manufacturers (2016-2021)
    Table 15. Ranking of Global Top Intracranial Atherosclerotic Disease Treatment Manufacturers by Revenue (US$ Million) in 2020
    Table 16. Intracranial Atherosclerotic Disease Treatment Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 17. Intracranial Atherosclerotic Disease Treatment Revenue Share by Manufacturers (2016-2021)
    Table 18. Global Intracranial Atherosclerotic Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 19. Global Intracranial Atherosclerotic Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intracranial Atherosclerotic Disease Treatment as of 2020)
    Table 20. Key Manufacturers Intracranial Atherosclerotic Disease Treatment Price (2016-2021) (US$/Unit)
    Table 21. Intracranial Atherosclerotic Disease Treatment Manufacturers Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Intracranial Atherosclerotic Disease Treatment Product Type
    Table 23. Date of International Manufacturers Enter into Intracranial Atherosclerotic Disease Treatment Market
    Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 25. Global Intracranial Atherosclerotic Disease Treatment Sales by Type (2016-2021) (K Units)
    Table 26. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Type (2016-2021)
    Table 27. Global Intracranial Atherosclerotic Disease Treatment Revenue by Type (2016-2021) (US$ Million)
    Table 28. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Type (2016-2021)
    Table 29. Intracranial Atherosclerotic Disease Treatment Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
    Table 30. Global Intracranial Atherosclerotic Disease Treatment Sales Forecast by Type (2022-2027) & (K Units)
    Table 31. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share Forecast by Type (2022-2027)
    Table 32. Global Intracranial Atherosclerotic Disease Treatment Revenue Forecast V (2022-2027) & (US$ Million)
    Table 33. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share Forecast by Type (2022-2027)
    Table 34. Global Intracranial Atherosclerotic Disease Treatment Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
    Table 35. Global Intracranial Atherosclerotic Disease Treatment Sales by Application (2016-2021) (K Units)
    Table 36. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Application (2016-2021)
    Table 37. Global Intracranial Atherosclerotic Disease Treatment Revenue by Application (2016-2021) (US$ Million)
    Table 38. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Application (2016-2021)
    Table 39. Intracranial Atherosclerotic Disease Treatment Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
    Table 40. Global Intracranial Atherosclerotic Disease Treatment Sales Forecast by Application (2022-2027) & (K Units)
    Table 41. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share Forecast by Application (2022-2027)
    Table 42. Global Intracranial Atherosclerotic Disease Treatment Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 43. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share Forecast by Application (2022-2027)
    Table 44. Global Intracranial Atherosclerotic Disease Treatment Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
    Table 45. China Intracranial Atherosclerotic Disease Treatment Sales (K Units) of Key Companies (2016-2021)
    Table 46. China Intracranial Atherosclerotic Disease Treatment Sales Share by Company (2016-2021)
    Table 47. China Intracranial Atherosclerotic Disease Treatment Revenue (US$ Million) by Company (2016-2021)
    Table 48. China Intracranial Atherosclerotic Disease Treatment Revenue Share by Company (2016-2021)
    Table 49. China Intracranial Atherosclerotic Disease Treatment Sales (K Units) by Type (2016-2021)
    Table 50. China Intracranial Atherosclerotic Disease Treatment Sales Share by Type (2016-2021)
    Table 51. China Intracranial Atherosclerotic Disease Treatment Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 52. China Intracranial Atherosclerotic Disease Treatment Price (US$/Unit) by Type (2016-2021)
    Table 53. China Intracranial Atherosclerotic Disease Treatment Sales (K Units) by Type (2022-2027)
    Table 54. China Intracranial Atherosclerotic Disease Treatment Sales Share by Type (2022-2027)
    Table 55. China Intracranial Atherosclerotic Disease Treatment Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 56. China Intracranial Atherosclerotic Disease Treatment Revenue Share by Type (2022-2027)
    Table 57. China Intracranial Atherosclerotic Disease Treatment Price (US$/Unit) by Type (2022-2027)
    Table 58. China Intracranial Atherosclerotic Disease Treatment Sales (K Units) by Application (2016-2021)
    Table 59. China Intracranial Atherosclerotic Disease Treatment Sales Share by Application (2016-2021)
    Table 60. China Intracranial Atherosclerotic Disease Treatment Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 61. China Intracranial Atherosclerotic Disease Treatment Price (US$/Unit) by Application (2016-2021)
    Table 62. China Intracranial Atherosclerotic Disease Treatment Sales (K Units) by Application (2022-2027)
    Table 63. China Intracranial Atherosclerotic Disease Treatment Sales Share by Application (2022-2027)
    Table 64. China Intracranial Atherosclerotic Disease Treatment Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 65. China Intracranial Atherosclerotic Disease Treatment Revenue Share by Application (2022-2027)
    Table 66. China Intracranial Atherosclerotic Disease Treatment Price (US$/Unit) by Application (2022-2027)
    Table 67. North America Intracranial Atherosclerotic Disease Treatment Sales by Country (2016-2021) & (K Units)
    Table 68. North America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country (2016-2021)
    Table 69. North America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2016-2021) & (US$ Million)
    Table 70. North America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country (2016-2021)
    Table 71. Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales by Region (2016-2021) & (K Units)
    Table 72. Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2016-2021)
    Table 73. Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue by Region (2016-2021) & (US$ Million)
    Table 74. Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region (2016-2021)
    Table 75. Europe Intracranial Atherosclerotic Disease Treatment Sales by Country (2016-2021) & (K Units)
    Table 76. Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country (2016-2021)
    Table 77. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country (2016-2021) & (US$ Million)
    Table 78. Europe Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country (2016-2021)
    Table 79. Latin America Intracranial Atherosclerotic Disease Treatment Sales by Country (2016-2021) & (K Units)
    Table 80. Latin America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country (2016-2021)
    Table 81. Latin Americaa Intracranial Atherosclerotic Disease Treatment Revenue by Country (2016-2021) & (US$ Million)
    Table 82. Latin America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country (2016-2021)
    Table 83. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales by Country (2016-2021) & (K Units)
    Table 84. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country (2016-2021)
    Table 85. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue by Country (2016-2021) & (US$ Million)
    Table 86. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country (2016-2021)
    Table 87. Stryker Corporation Information
    Table 88. Stryker Description and Business Overview
    Table 89. Stryker Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 90. Stryker Intracranial Atherosclerotic Disease Treatment Product
    Table 91. Stryker Recent Development
    Table 92. Balt Corporation Information
    Table 93. Balt Description and Business Overview
    Table 94. Balt Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 95. Balt Product
    Table 96. Balt Recent Development
    Table 97. TERUMO Corporation Information
    Table 98. TERUMO Description and Business Overview
    Table 99. TERUMO Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 100. TERUMO Product
    Table 101. TERUMO Recent Development
    Table 102. MicroPort Corporation Information
    Table 103. MicroPort Description and Business Overview
    Table 104. MicroPort Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 105. MicroPort Product
    Table 106. MicroPort Recent Development
    Table 107. Acandis Corporation Information
    Table 108. Acandis Description and Business Overview
    Table 109. Acandis Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 110. Acandis Product
    Table 111. Acandis Recent Development
    Table 112. Intracranial Atherosclerotic Disease Treatment Market Trends
    Table 113. Intracranial Atherosclerotic Disease Treatment Market Drivers
    Table 114. Intracranial Atherosclerotic Disease Treatment Market Challenges
    Table 115. Intracranial Atherosclerotic Disease Treatment Market Restraints
    Table 116. Intracranial Atherosclerotic Disease Treatment Customers List
    Table 117. Intracranial Atherosclerotic Disease Treatment Distributors List
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Intracranial Atherosclerotic Disease Treatment Product Picture
    Figure 2. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type in 2020 & 2027
    Figure 3. Stent Product Picture
    Figure 4. PTA Balloon Product Picture
    Figure 5. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application in 2020 & 2027
    Figure 6. Hospital
    Figure 7. Clinic
    Figure 8. Other
    Figure 9. Intracranial Atherosclerotic Disease Treatment Report Years Considered
    Figure 10. Global Intracranial Atherosclerotic Disease Treatment Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Intracranial Atherosclerotic Disease Treatment Market Size 2016-2027 (US$ Million)
    Figure 12. Global Intracranial Atherosclerotic Disease Treatment Sales 2016-2027 (K Units)
    Figure 13. Global Intracranial Atherosclerotic Disease Treatment Market Size Market Share by Region: 2021 Versus 2027
    Figure 14. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2016-2021)
    Figure 15. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region in 2020
    Figure 16. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region (2016-2021)
    Figure 17. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region in 2020
    Figure 18. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Manufacturer in 2020
    Figure 19. The Top 10 and 5 Players Market Share by Intracranial Atherosclerotic Disease Treatment Revenue in 2020
    Figure 20. Intracranial Atherosclerotic Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 21. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2016-2021)
    Figure 22. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type in 2020
    Figure 23. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2016-2021)
    Figure 24. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type in 2020
    Figure 25. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2016-2021)
    Figure 26. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application in 2020
    Figure 27. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2016-2021)
    Figure 28. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application in 2020
    Figure 29. China Intracranial Atherosclerotic Disease Treatment Sales Growth Rate 2016-2027 (K Units)
    Figure 30. China Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 31. China Intracranial Atherosclerotic Disease Treatment Market Share in Global Market 2016-2027
    Figure 32. China 5 and 10 Largest Intracranial Atherosclerotic Disease Treatment Players Market Share by Revenue in Intracranial Atherosclerotic Disease Treatment in 2020
    Figure 33. China Intracranial Atherosclerotic Disease Treatment Revenue Share by Type (2016-2021)
    Figure 34. China Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate by Type in 2016 & 2020
    Figure 35. China Intracranial Atherosclerotic Disease Treatment Revenue Share by Application (2016-2021)
    Figure 36. China Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate by Application in 2016 & 2020
    Figure 37. North America Intracranial Atherosclerotic Disease Treatment Sales Growth Rate 2016-2021 (K Units)
    Figure 38. North America Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 39. North America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country in 2020
    Figure 40. North America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country in 2020
    Figure 41. United States Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 42. United States Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. Canada Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 44. Canada Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. Europe Intracranial Atherosclerotic Disease Treatment Sales Growth Rate 2016-2021 (K Units)
    Figure 46. Europe Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 47. Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country in 2020
    Figure 48. Europe Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country in 2020
    Figure 49. Germany Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 50. Germany Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 51. France Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 52. France Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 53. U.K. Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 54. U.K. Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 55. Italy Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 56. Italy Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 57. Russia Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 58. Russia Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 59. Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales Growth Rate 2016-2021 (K Units)
    Figure 60. Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 61. Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region in 2020
    Figure 62. Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region in 2020
    Figure 63. China Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 64. China Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 65. Japan Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 66. Japan Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 67. South Korea Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 68. South Korea Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 69. India Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 70. India Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 71. Australia Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 72. Australia Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 73. China Taiwan Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 74. China Taiwan Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 75. Indonesia Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 76. Indonesia Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 77. Thailand Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 78. Thailand Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 79. Malaysia Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 80. Malaysia Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 81. Latin America Intracranial Atherosclerotic Disease Treatment Sales Growth Rate 2016-2021 (K Units)
    Figure 82. Latin America Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 83. Latin America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country in 2020
    Figure 84. Latin America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country in 2020
    Figure 85. Mexico Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 86. Mexico Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 87. Brazil Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 88. Brazil Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 89. Argentina Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 90. Argentina Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 91. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales Growth Rate 2016-2021 (K Units)
    Figure 92. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 93. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country in 2020
    Figure 94. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country in 2020
    Figure 95. Turkey Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 96. Turkey Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 97. Saudi Arabia Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 98. Saudi Arabia Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 99. UAE Intracranial Atherosclerotic Disease Treatment Sales Growth Rate (2016-2021) (K Units)
    Figure 100. UAE Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 101. Intracranial Atherosclerotic Disease Treatment Value Chain
    Figure 102. Channels of Distribution
    Figure 103. Distributors Profiles
    Figure 104. Bottom-up and Top-down Approaches for This Report
    Figure 105. Data Triangulation
    Figure 106. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Stryker
Balt
TERUMO
MicroPort
Acandis
Frequently Asked Questions
Intracranial Atherosclerotic Disease Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Intracranial Atherosclerotic Disease Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Intracranial Atherosclerotic Disease Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports